Thomas Schinecker, Roche CEO (ddp images/Sipa USA/Sipa via AP Images)

Roche dou­bles down on high-im­pact projects af­ter slash­ing 20% of its pipeline

Roche has axed one-fifth of its pipeline since the third quar­ter of 2023 as part of a broad­er port­fo­lio re­view aimed at boost­ing the com­pa­ny …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA